Novo CEO pressed by Senate to cut selling prices of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen instructed lawmakers the company would think about new talks with insurers with regard to the record price ranges of Wegovy and copyright whenever they pledge to help keep the medicines on their formularies. https://marioijmrv.elbloglibre.com/30579474/5-essential-elements-for-healthcare-news